文献速递肺外科

低剂量CT肺癌筛查中良性病变的手术与侵入性诊断操作罕见

Surgery and invasive diagnostic procedures for benign disease are rare in a large low-dose computed tomography lung cancer screening program.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-09-08

该研究回顾性分析了2012年1月至2017年6月单中心低剂量CT肺癌筛查项目,共3280例受筛者,其中345例(10.5%)为Lung CT Screening Reporting and Data System 4类可疑发现。结果显示,良性病变接受手术切除的比例为0.43%,任何针对良性病变的侵入性干预合计发生率仅0.95%,且60天内无操作后死亡,提示对不必要干预的担忧被夸大。

要点

  • 60天内无操作后死亡,围操作期并发症罕见。

核心结论

  • 良性病变手术切除率为0.43%,任何侵入性诊断或治疗干预合计发生率仅0.95%,对不必要干预的担忧被夸大。
  • 多学科团队(包括胸外科医生)对维持肺癌筛查中适当的干预率至关重要。

研究设计与样本

  • 回顾性队列研究,纳入2012年1月至2017年6月单中心低剂量CT肺癌筛查项目全部患者,随访至2019年1月,共3280例受筛者。

主要发现

  • 345例(10.5%)有Lung CT Screening Reporting and Data System 4类发现,311例完成随访,其中93例(29.9%)诊断为肺癌。
  • 60天内无操作后死亡。

临床怎么用

  • 低剂量CT肺癌筛查中良性病变干预率低,不应因担忧过度干预而阻碍筛查推广。
  • 胸外科参与的多学科团队有助于维持合理的干预率。

局限性

  • 单中心回顾性研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lung cancer screening with low-dose chest computed tomography improves survival. However, concerns about overdiagnosis and unnecessary interventions persist. We reviewed our lung cancer screening program to determine the rate of surgery and invasive procedures for nonmalignant disease. METHODS: We reviewed all patients undergoing lung cancer screening from January 2012 to June 2017 with follow-up through January 2019. Patients with suspicious findings (Lung CT Screening Reporting and Data System 4) were referred for further evaluation. RESULTS: Of 3280 patients screened, 345 (10.5%) had Lung CT Screening Reporting and Data System 4 findings. A total of 311 patients had complete follow-up, of whom 93 (29.9%) were diagnosed with lung cancer. Eighty-three patients underwent lung surgery (2.5% of screened patients). Forty patients underwent lobectomy (48.2%), 3 patients (3.6%) underwent bilobectomy, and 40 patients (48.2%) underwent sublobar resection. Fourteen patients underwent surgery for benign disease (0.43% of screened patients). Fifty-four patients, 5 with benign disease, had at least 1 invasive diagnostic procedure but never underwent surgery. The incidence of any invasive intervention for nonmalignant disease was 0.95% (31/3280 patients). There were no postprocedural deaths within 60 days. Twenty-five patients (0.76%) underwent stereotactic body radiation therapy; 19 patients (76%) had presumed lung cancer without pretreatment pathologic confirmation. CONCLUSIONS: Surgical resection for benign disease occurred in 0.43% of patients undergoing lung cancer screening. The combined incidence of any invasive diagnostic or therapeutic intervention, including surgical resection, for benign disease was only 0.95%. Periprocedural complications were rare. These results indicate that concern over unnecessary interventions is overstated and should not hinder adoption of lung cancer screening. A multidisciplinary team approach, including thoracic surgeons, is critical to maintain an appropriate rate of interventions in lung cancer screening.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ho H, Williamson C, Regis SM, et al. Surgery and invasive diagnostic procedures for benign disease are rare in a large low-dose computed tomography lung cancer screening program. J Thorac Cardiovasc Surg. 2020. PMID: 33023746. doi:10.1016/j.jtcvs.2020.08.109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。